Patents by Inventor Chetan Doshi

Chetan Doshi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230331778
    Abstract: The present invention relates to an improved process for the synthesis of Etelcalcetide and its analogs by solid phase synthesis of Fmoc protected amino acids in a sequential manner, followed by acetylation of terminal D-cys and cleavage of peptide from solid support. The crude heptapeptide thus obtained is reduced using Tris(2-carboxyethyl) phosphine hydrochloride, purified and oxidized with L-cysteine. The oxidized Etelcalcetide is purified and salt exchanged using a one-step reverse phase chromatography process. The purified Etelcalcetide hydrochloride is then precipitated using organic solvents, concentrated and lyophilized to purity of greater than 99.0%.
    Type: Application
    Filed: August 31, 2021
    Publication date: October 19, 2023
    Inventors: Lester John Lobo, Muralidharan Chandrakesan, Chetan Doshi, Shailesh Lalchand Chanadak, Nandlal Gopal Yadav, Nikhil Umesh Mohe, Kodandaraman Vishwanathan, Praful Shamrao Chavre
  • Publication number: 20060115526
    Abstract: This invention provides coated pellets comprising a) a pellet core which comprises venlafaxine hydrochloride; b) a first coating which comprises a lipophilic layer or a sparingly water-soluble layer, and c) a second coating which comprises a water-insoluble polymer or polymer mixture. In another aspect this invention provides compositions which comprises the coated pellets. In a further aspect, the invention provides a process for preparing the coated pellets which process avoids use of organic solvents at least for the second coating.
    Type: Application
    Filed: March 26, 2004
    Publication date: June 1, 2006
    Inventors: Chetan Doshi, Dinesh Gopinathan, Sushrut Kulkarni, Mangesh Sukthankar, Prashant Thakker
  • Publication number: 20060099266
    Abstract: The invention relates to an orally administrable pharmaceutical comprising an alginate matrix consisting of a water-soluble alginate salt and a complex salt of alginic acid, a macrolide, and an inorganic salt characterized in that the inorganic salt is capable of donating a proton and has a pKa value in water of 4.0 to 9.0.
    Type: Application
    Filed: December 22, 2003
    Publication date: May 11, 2006
    Inventors: Rakhi Rohra, Mallika Tushakiran, Chetan Doshi, Virendra Khanapure, Dinesh Nambiar, Erich Zeisl
  • Publication number: 20050249814
    Abstract: A pharmaceutical composition having improved solubility comprising a hydrophobic drug or pharmaceutically acceptable salt thereof and a compound having at least one carboxylic acid moiety, wherein the molar ratio of the compound having at least one carboxylic acid moiety to the hydrophobic drug or pharmaceutically acceptable salt thereof is from about 0.1:1 to about 25:1. The pharmaceutical composition exhibits rapid dissolution upon contact with physiological solvents, such as water, saliva or gastrointestinal fluids.
    Type: Application
    Filed: May 6, 2005
    Publication date: November 10, 2005
    Inventors: Gary Barbera, Chetan Doshi, Mahendra Patel, Pablo Davila, Satishkumar Patel